Navigation Links
Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
Date:8/21/2007

financing to

maintain the Company's planned operations;

* the adequacy of the Company's patents and proprietary rights;

* the impact of litigation that has been brought against the Company and

its officers and directors and any proposed settlement of such

litigation;

* and the other risks described under Certain Risks and Uncertainties

Related to the Company's Business, as contained in the Company's Annual

Report on Form 10-K and Quarterly Report on Form 10-Q.

The Company does not undertake to update any forward-looking statements. There are a number of factors that could cause actual results and developments to differ materially. For a discussion of those risks and uncertainties, please see the Company's Annual Report on Form 10-K for 2006 and its most recent quarterly report on Form 10-Q.

CONTACT:

For Genta Incorporated

Tara Spiess

TS Communications Group, LLC

(908) 286-3980

info@genta.com


'/>"/>
SOURCE Genta Incorporated

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5

Related medicine technology :

1. Genta Announces Results of Phase 1 Study Using Genasense Administered by Intermittent Subcutaneous Injection
2. Genta Incorporated to Present Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
3. Malvern initiates European user group meetings for chemical imaging
4. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
5. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... 2014 WuXi PharmaTech (Cayman) Inc. (NYSE: ... platform company serving the pharmaceutical, biotechnology, and medical device ... and the United States , today ... Tel Aviv area of Israel.  ... broad platform of integrated R&D services to local customers. ...
(Date:10/30/2014)... , Oct. 30, 2014  Electronic health ... as a result of government initiatives and the ... healthcare providers have invested over the past five ... of health IT, and U.S. clinicians use them ... - http://photos.prnewswire.com/prnh/20141029/155278LOGO Frost ...
(Date:10/30/2014)... 2014 CVS Health (NYSE: CVS ) ... three leading regional health systems to enhance access to high-quality, ... include Baptist Health System in Alabama ; ... in Pennsylvania , Northwest Medical Center, including ... Tennova Healthcare in Tennessee ; and Premier ...
Breaking Medicine Technology:WuXi AppTec Launches Representative Office in Israel, Forms Strategic Collaboration with Pontifax 2Electronic Health Record Usability: CIOs Weigh In 2Electronic Health Record Usability: CIOs Weigh In 3Electronic Health Record Usability: CIOs Weigh In 4CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 2CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 3CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 4
... DEERFIELD, Ill. and OSAKA, Japan, February 23, 2011 ... that Takeda Global Research & Development Center, Inc. ... the U.S. Food and Drug Administration (FDA) for ... chlorthalidone (CLD) for the treatment of hypertension, or ...
... Pharmaxis, a global specialty pharmaceutical company focused on therapeutic ... the commercial launch of ARIDOL® (mannitol inhalation powder) ... challenge test in more than two decades and the ... used to assess bronchial hyperresponsiveness in patients six years ...
Cached Medicine Technology:Takeda Submits New Drug Application in the U.S. for Azilsartan Medoxomil Plus Chlorthalidone, an Investigational Fixed-Dose Combination for the Treatment of Hypertension 2Takeda Submits New Drug Application in the U.S. for Azilsartan Medoxomil Plus Chlorthalidone, an Investigational Fixed-Dose Combination for the Treatment of Hypertension 3Pharmaxis Launches ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness 2Pharmaxis Launches ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness 3Pharmaxis Launches ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness 4Pharmaxis Launches ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness 5
(Date:10/31/2014)... study of its kind, Rice University researchers have mapped ... cancer cells to become metastatic. The research reveals a ... to both migrate and form new tumors. Researchers say ... that interfere with the genetic switches that cancer must ... tumor cells -- two of the main players in ...
(Date:10/31/2014)... 31, 2014 The Memory Healer review published ... Alexander Lynch, whose father suffered from Alzheimer's disease. , ... caused by his father's disease. His father pointed a gun ... crucial moment when the author of this method understood that ... , The Memory Healer program is based on years of ...
(Date:10/31/2014)... This Method to get a ... for practitioners. , The Hypopresive (aka Hipopressive) ... and Movement specializing in physical rehabilitation. Dr. Marcel ... reeducation that traditional abdominal exercises after pregnancy increased ... etc. , The Hipopressives exercises pull back in ...
(Date:10/31/2014)... Lake City, UT (PRWEB) October 31, 2014 ... announce the new Activz Silver line offering ... and cleansing wipes. For over a century, silver has ... formula found in Activz Silver products is the most ... U.S. patents, has a unique chemical structure that supports ...
(Date:10/31/2014)... may make it hard for you to remember simple things, ... house keys, a small study suggests. Tests on 18 ... called spatial memory -- was impaired when sleep apnea disrupted ... sleep weren,t affected. REM sleep is the deepest level of ... the first time that sleep apnea, an increasingly common medical ...
Breaking Medicine News(10 mins):Health News:Decoding the emergence of metastatic cancer stem cells 2Health News:Decoding the emergence of metastatic cancer stem cells 3Health News:"Memory Healer" Review Reveals a New Natural Remedy Guide for Managing Memory Loss 2Health News:Super Models and European Celebrities’ Secret Flat Tummy System Comes to America 2Health News:Super Models and European Celebrities’ Secret Flat Tummy System Comes to America 3Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 2Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 3Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 4Health News:Sleep Apnea May Steal Some of Your Memory: Study 2
... On June 7th, Little Hearts, Inc. held their 13th annual ... support services they offer is their "Picture of Hope" -- ... age from infant to 50 of all different types of ... TOF and Tricuspid Atresia. "HOPE" is shared with others on ...
... Too much late viewing adding to sleep deficit, researchers warn ... a dark night sky and fatigue probably signaled it was ... Stewart and the Desperate Housewives are more influential ... many Americans, chronic sleep deprivation, a new study says. , ...
... ... for tackling Alzheimer,s disease will be discussed in detail this week at ... with Novel Therapeutics conference, to be held as part of the 8th ... Neurological Research, a private medical group, inc. in Los Angeles, will present ...
... Taste and nutrition have long been topics of ... much uncertainty about what products are healthy in the ... by delivering delicious, convenient and nutritious foods to help ... release of Sunsweet Antioxidant Blend, a delicious combination of ...
... , Coalition Works to Ensure Access, Quality Healthcare for All ... the Coalition for Patients, Rights (TM) announced that it ... him to support the utilization of a broad spectrum of ... healthcare system. In its correspondence to the White House, ...
... impedance driving performance parameters up and driving manufacturing ... Sensors Expo & Conference - ... precision calibration products (Rejustors), today announced a family ... respiratory and industrial HVAC applications. Microbridge is demonstrating ...
Cached Medicine News:Health News:Members of National CHD Organization Unite for Little Hearts' Celebration and Assemble for 'Picture of Hope' 2Health News:Glowing TV Screens Keeping Americans Up at Night 2Health News:New Immune Approach for Treatment of Alzheimer's Disease 2Health News:New Immune Approach for Treatment of Alzheimer's Disease 3Health News:New Immune Approach for Treatment of Alzheimer's Disease 4Health News:Sunsweet Introduces New Antioxidant Blend, a Delicious Blend of High Antioxidant Fruits 2Health News:Sunsweet Introduces New Antioxidant Blend, a Delicious Blend of High Antioxidant Fruits 3Health News:Rights, Access to Healthcare Providers of Choice at Risk 2Health News:Rights, Access to Healthcare Providers of Choice at Risk 3Health News:Microbridge Technologies Announces Micro-Flow Differential Pressure Sensors for Medical Respiration and Industrial HVAC Applications 2Health News:Microbridge Technologies Announces Micro-Flow Differential Pressure Sensors for Medical Respiration and Industrial HVAC Applications 3
... advanced 3D matching algorithms developed by Medtronic ... merges image sets from a variety of ... regardless of acquisition orientation. Stealthmerge even correlates ... requirement to scan tissue outside the targeted ...
3D Cranial is the most widely used surgical navigation software. Navigate with confidence and ease with our displayed Zone of Accuracy and several fully automated features. 3D Cranial offers seamless...
... The modular Doro headrest system ... and non-invasive applications in head ... be adapted to all standard ... decisive advantages and improvements in ...
Mc Kenzie twist drill, diameter 13 mm....
Medicine Products: